Advanced Medical Solutions Group plc
AMS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £474 | £437 | £454 | £454 |
| - Cash | £19 | £17 | £135 | £60 |
| + Debt | £82 | £87 | £90 | £9 |
| Enterprise Value | £537 | £507 | £409 | £403 |
| Revenue | £111 | £110 | £68 | £63 |
| % Growth | 1.1% | 61.1% | 7.7% | – |
| Gross Profit | £59 | £49 | £37 | £34 |
| % Margin | 53.5% | 44.9% | 54.3% | 54.6% |
| EBITDA | £20 | £18 | £9 | £16 |
| % Margin | 17.9% | 16.4% | 13% | 24.8% |
| Net Income | £6 | £3 | £4 | £7 |
| % Margin | 5.6% | 2.7% | 6.1% | 11% |
| EPS Diluted | 0.028 | 0.013 | 0.019 | 0.032 |
| % Growth | 113.5% | -30.7% | -39.8% | – |
| Operating Cash Flow | £15 | £9 | £7 | £8 |
| Capital Expenditures | -£2 | -£3 | -£2 | -£2 |
| Free Cash Flow | £13 | £6 | £5 | £6 |